Skip to main content
    • Aa
    • Aa

Insulin gene therapy from design to beta cell generation

  • Ahter D. Sanlioglu (a1) (a2), Hasan Ali Altunbas (a1) (a3), Mustafa Kemal Balci (a1) (a3), Thomas S. Griffith (a4) and Salih Sanlioglu (a1) (a2)...

Despite the fact that insulin injection can protect diabetic patients from developing diabetes-related complications, recent meta-analyses indicate that rapid and long-acting insulin analogues only provide a limited benefit compared with conventional insulin regarding glycemic control. As insulin deficiency is the main sequel of type-1 diabetes (T1D), transfer of the insulin gene-by-gene therapy is becoming an attractive treatment modality even though T1D is not caused by a single genetic defect. In contrast to human insulin and insulin analogues, insulin gene therapy targets to supplement patients not only with insulin but also with C-peptide. So far, insulin gene therapy has had limited success because of delayed and/or transient gene expression. Sustained insulin gene expression is now feasible using current gene-therapy vectors providing patients with basal insulin coverage, but management of postprandial hyperglycaemia is still difficult to accomplish because of the inability to properly control insulin secretion. Enteroendocrine cells of the gastrointestinal track (K cells and L cells) may be ideal targets for insulin gene therapy, but cell-targeting difficulties have limited practical implementation of insulin gene therapy for diabetes treatment. Therefore, recent gene transfer technologies developed to generate authentic beta cells through transdifferentiation are also highlighted in this review.

Corresponding author
*Corresponding author: Salih Sanlioglu VMD, Human Gene and Cell Therapy Center, Akdeniz University Hospitals and Clinics, B Block, 1st Floor, Campus, Antalya, Turkey. Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

2 H.P. Moore (1983) Expressing a human proinsulin cDNA in a mouse ACTH-secreting cell. Intracellular storage, proteolytic processing, and secretion on stimulation. Cell 35, 531-538

3 H. Dong , S.L. Woo (2001) Hepatic insulin production for type 1 diabetes. Trends in Endocrinology and Metabolism 12, 441-446

4 M.S. Wong , W.J. Hawthorne and N. Manolios (2010) Gene therapy in diabetes. Self and Nonself 1, 165-175

5 A. Hughes (2010) Gene therapy to improve pancreatic islet transplantation for Type 1 diabetes mellitus. Current Diabetes Review 6, 274-284

6 J. Bagley (2008) Gene therapy in type 1 diabetes. Critical Reviews in Immunology 28, 301-324

7 P.C. Nett , H.W. Sollinger and T. Alam (2003) Hepatic insulin gene therapy in insulin-dependent diabetes mellitus. American Journal of Transplantation 3, 1197-1203

8 G.P. Kobinger (2004) Transduction of human islets with pseudotyped lentiviral vectors. Human Gene Therapy 15, 211-219

9 B. Zhang (2001) A highly efficient and consistent method for harvesting large volumes of high-titre lentiviral vectors. Gene Therapy 8, 1745-1751

10 K. Doerschug (2002) First-generation adenovirus vectors shorten survival time in a murine model of sepsis. Journal of Immunol 169, 6539-6545

11 A.R. Barbu , G. Akusjarvi and N. Welsh (2005) Adenoviral-mediated transduction of human pancreatic islets: importance of adenoviral genome for cell viability and association with a deficient antiviral response. Endocrinology 146, 2406-2414

12 J.A. Zhang (2009) Hepatic insulin gene therapy diminishes liver glycogen despite insulin responsive transcriptional effects in diabetic CD-1 mice. Journal of Gene Medicine 11, 588-597

13 S. Sanlioglu (2001) Rate limiting steps of AAV transduction and implications for human gene therapy. Current Gene Therapy 1, 137-147

14 S. Sanlioglu and J.F. Engelhardt (1999) Cellular redox state alters recombinant adeno-associated virus transduction through tyrosine phosphatase pathways. Gene Therapy 6, 1427-1437

15 S. Sanlioglu (2000) Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation. Journal of Virology 74, 9184-9196

16 S. Sanlioglu , P. Benson and J.F. Engelhardt (2000) Loss of ATM function enhances recombinant adeno-associated virus transduction and integration through pathways similar to UV irradiation. Virology 268, 68-78

17 R. Alba , A. Bosch and M. Chillon (2005) Gutless adenovirus: last-generation adenovirus for gene therapy. Gene Therapy 12(Suppl 1), S18-S27

18 D.J. Palmer and P. Ng (2005) Helper-dependent adenoviral vectors for gene therapy. Human Gene Therapy 16, 1-16

19 T.M. Kolodka (1995) Gene therapy for diabetes mellitus in rats by hepatic expression of insulin. Proceedings of the National Academy of Sciences of the United States of America 92, 3293-3297

20 L. Falqui (1999) Reversal of diabetes in mice by implantation of human fibroblasts genetically engineered to release mature human insulin. Human Gene Therapy 10, 1753-1762

21 A. Auricchio (2002) Constitutive and regulated expression of processed insulin following in vivo hepatic gene transfer. Gene Therapy 9, 963-971

22 F. Vollenweider (1995) Processing of proinsulin by furin, PC2, and PC3 in (co) transfected COS (monkey kidney) cells. Diabetes 44, 1075-1080

24 G.D. Simonson (1996) Synthesis and processing of genetically modified human proinsulin by rat myoblast primary cultures. Human Gene Therapy 7, 71-78

25 J.C. Irminger , K. Meyer and P. Halban (1996) Proinsulin processing in the rat insulinoma cell line INS after overexpression of the endoproteases PC2 or PC3 by recombinant adenovirus. Biochemical Journal 320, 11-15

27 H. Dong (2001) Hepatic insulin expression improves glycemic control in type 1 diabetic rats. Diabetes Research and Clinical Practice 52, 153-163

28 S.I. Tanaka (2004) Daily nasal inoculation with the insulin gene ameliorates diabetes in mice. Diabetes Research and Clinical Practice 63, 1-9

29 Y.M. Park (2005) Safety and efficacy of adeno-associated viral vector-mediated insulin gene transfer via portal vein to the livers of streptozotocin-induced diabetic Sprague-Dawley rats. Journal of Gene Medicine 7, 621-629

30 M. Elsner (2012) Reversal of diabetes through gene therapy of diabetic rats by hepatic insulin expression via lentiviral transduction. Molecular Therapy 20, 918-926

31 D. Lu (1998) Regulatable production of insulin from primary-cultured hepatocytes: insulin production is up-regulated by glucagon and cAMP and down-regulated by insulin. Gene Therapy 5, 888-895

32 J. Han (2011) Remission of diabetes by insulin gene therapy using a hepatocyte-specific and glucose-responsive synthetic promoter. Molecular Therpy 19, 470-478

35 P.M. Thule , J. Liu and L.S. Phillips (2000) Glucose regulated production of human insulin in rat hepatocytes. Gene Therapy 7, 205-214

36 P.M. Thule (2006) Hepatic insulin gene therapy prevents deterioration of vascular function and improves adipocytokine profile in STZ-diabetic rats. American Journal of Physiology, Endocrinology and Metabolism 290, E114-E122

37 D. Argaud (1996) Regulation of rat liver glucose-6-phosphatase gene expression in different nutritional and hormonal states: gene structure and 5′-flanking sequence. Diabetes 45, 1563-1571

38 R. Chen (2000) Glucose-stimulated and self-limiting insulin production by glucose 6-phosphatase promoter driven insulin expression in hepatoma cells. Gene Therapy 7, 1802-1809

39 R. Chen , M.L. Meseck and S.L. Woo (2001) Auto-regulated hepatic insulin gene expression in type 1 diabetic rats. Molecular Therapy 3, 584-590

40 B.R. Burkhardt (2003) Glucose-responsive expression of the human insulin promoter in HepG2 human hepatoma cells. Annals of the New York Academy of Sciences 1005, 237-241

42 S. Sanlioglu , D. Duan and J.F. Engelhardt (1999) Two independent molecular pathways for recombinant adeno-associated virus genome conversion occur after UV-C and E4orf6 augmentation of transduction. Human Gene Therapy 10, 591-602

43 K. Yasutomi (2003) Intravascular insulin gene delivery as potential therapeutic intervention in diabetes mellitus. Biochemical and Biophysical Research Communication 310, 897-903

44 Y.W. Yang and C.K. Chao (2003) Incorporation of calcium phosphate enhances recombinant adeno-associated virus-mediated gene therapy in diabetic mice. Journal of Gene Medicine 5, 417-424

45 P.Y. Hsu and Y.W. Yang (2005) Effect of polyethylenimine on recombinant adeno-associated virus mediated insulin gene therapy. Journal of Gene Medicine 7, 1311-1321

46 P.Y. Hsu , R.M. Kotin and Y.W. Yang (2008) Glucose- and metabolically regulated hepatic insulin gene therapy for diabetes. Pharmaceutical Research 25, 1460-1468

47 D.G. Brockstedt (1999) Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration. Clinical Immunology 92, 67-75

48 T.R. Flotte (2004) Immune responses to recombinant adeno-associated virus vectors: putting preclinical findings into perspective. Human Gene Therapy 15, 716-717

49 J.Y. Sun (2003) Immune responses to adeno-associated virus and its recombinant vectors. Gene Therapy 10, 964-976

50 V.M. Rivera (2000) Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum. Science 287, 826-830

51 A.T. Cheung (2000) Glucose-dependent insulin release from genetically engineered K cells. Science 290, 1959-1962

52 J.A. Corbett (2001) K cells: a novel target for insulin gene therapy for the prevention of diabetes. Trends in Endocrinology and Metabolism 12, 140-142

53 S.C. Tang and A. Sambanis (2004) Differential rAAV2 transduction efficiencies and insulin secretion profiles in pure and co-culture models of human enteroendocrine L-cells and enterocytes. Journal of Gene Medicine 6, 1003-1013

54 L. Niu (2008) Gene therapy for type 1 diabetes mellitus in rats by gastrointestinal administration of chitosan nanoparticles containing human insulin gene. World Journal of Gastroenterology 14, 4209-4215

55 P.A. Halban (2001) Gene and cell-replacement therapy in the treatment of type 1 diabetes: how high must the standards be set? Diabetes 50, 2181-2191

56 J. Wahren , A. Kallas and A.A. Sima (2012) The clinical potential of C-peptide replacement in type 1 diabetes. Diabetes 61, 761-772

57 S. Kahraman (2011) Tracing of islet graft survival by way of in vivo fluorescence imaging. Diabetes Metabolism Research and Reviews 27, 575-583

58 A.M. Shapiro (2005) Strategic opportunities in clinical islet transplantation. Transplantation 79, 1304-1307

59 P. Collombat (2010) Pancreatic beta-cells: from generation to regeneration. Seminars in Cell and Developmental Biology 21, 838-844

60 F. Yi , G.H. Liu and J.C. Izpisua Belmonte (2012) Rejuvenating liver and pancreas through cell transdifferentiation. Cell Research 22, 616-619

61 S. Ferber (2000) Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nature Medicine 6, 568-572

63 I. Ber (2003) Functional, persistent, and extended liver to pancreas transdifferentiation. Journal of Biological Chemistry 278, 31950-31957

64 K. Shternhall-Ron (2007) Ectopic PDX-1 expression in liver ameliorates type 1 diabetes. Journal of Autoimmunity 28, 134-142

65 H. Kaneto (2007) Role of PDX-1 and MafA as a potential therapeutic target for diabetes. Diabetes Research and Clinical Practice 77(Suppl 1), S127-S137

67 A.Y. Wang (2007) Adenovirus transduction is required for the correction of diabetes using Pdx-1 or Neurogenin-3 in the liver. Molecular Therapy 15, 255-263

68 T. Sapir (2005) Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells. Proceedings of the National Academy of Sciences of the United States of America 102, 7964-7969

69 L. Baeyens and L. Bouwens (2008) Can beta-cells be derived from exocrine pancreas? Diabetes, Obesity and Metabolism 10(Suppl 4), 170-178

70 Q. Zhou (2008) In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455, 627-632

71 M. Mauda-Havakuk (2011) Ectopic PDX-1 expression directly reprograms human keratinocytes along pancreatic insulin-producing cells fate. PLoS One 6, e26298

72 N. Swales (2012) Plasticity of adult human pancreatic duct cells by neurogenin3-mediated reprogramming. PLoS One 7, e37055

J Roth (2012) Insulin's discovery: new insights on its ninetieth birthday. Diabetes Metabolism Research and Reviews 28, 293-304

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Expert Reviews in Molecular Medicine
  • ISSN: -
  • EISSN: 1462-3994
  • URL: /core/journals/expert-reviews-in-molecular-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Altmetric attention score

Full text views

Total number of HTML views: 3
Total number of PDF views: 25 *
Loading metrics...

Abstract views

Total abstract views: 209 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 22nd September 2017. This data will be updated every 24 hours.